(E)-3-Stilbenol

(E)-3-Stilbenol

SCHEMBL113158

Oc1cccc(/C=C/c2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.75
CCNB2 O95067 1/20 0.61
CDK1 P06493 1/20 0.61
CDK4 P11802 1/20 0.61
CCNB1 P14635 1/20 0.61
CCND1 P24385 1/20 0.61
CCNB3 Q8WWL7 1/20 0.61
ABL1 P00519 1/20 0.60
BCR P11274 1/20 0.60
CYSLTR2 Q9NS75 1/20 0.56
CYSLTR1 Q9Y271 1/20 0.56
MMP1 P03956 1/20 0.56
MMP2 P08253 1/20 0.56
MMP9 P14780 1/20 0.56
NFE2L2 Q16236 1/20 0.56
CYP19A1 P11511 1/20 0.56
MAOA P21397 1/20 0.56
MAOB P27338 1/20 0.56
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(E)-3-Stilbenol SCHEMBL5489745 1.00 LCK (0.75) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL113159 1.00 LCK (0.75) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL30364828 1.00 LCK (0.75) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419822 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419840 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419842 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419843 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419816 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
(E)-3-Stilbenol SCHEMBL9419819 0.98 LCK (0.72) LCKCCNB2CDK1CDK4CCNB1
SCHEMBL13338339 0.93 LCK (0.86) LCKCCNB2CDK1CDK4CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704801-A1 COMPOSITIONS COMPRISING NIACINAMIDE AND RESVERATROL SALICYLATE ELC Management LLC (US) 2026-03-11 EP claimed
WO-2024229025-A1 COMPOSITIONS COMPRISING NIACINAMIDE AND RESVERATROL SALICYLATE ELC MANAGEMENT LLC (US) 2024-11-07 WO claimed
US-10729630-B2 Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH THE PROCTER & GAMBLE COMPANY (US) 2020-08-04 US claimed
CN-105828786-B Shaping keratin fibres using AN AN active agent comprising a functional group selected from-C (═ O) -, -C (═ O) -H and-C (═ O) -O-) 宝洁公司 2020-07-07 CN claimed
CN-105828793-B Shaping keratin fibres using sugar 宝洁公司 2019-06-18 CN claimed
EP-3082494-B1 METHOD FOR SHAPING FIBROUS MATERIAL PROCTER & GAMBLE (US) 2018-12-05 EP claimed
EP-3082746-B1 SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE PROCTER & GAMBLE (US) 2018-11-28 EP claimed
EP-3082736-B1 SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID PROCTER & GAMBLE (US) 2018-08-08 EP claimed
EP-3082747-B1 SHAPING KERATIN FIBRES USING A SUGAR PROCTER & GAMBLE (US) 2018-07-04 EP claimed
EP-3082731-B1 SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH PROCTER & GAMBLE (US) 2018-07-04 EP claimed
WO-2015094837-A1 SHAPING KERATIN FIBRES USING CARBONATE ESTER THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
WO-2015094756-A1 SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE THE PROCTER & GAMBLE COMPANY (US) 2015-06-25 WO claimed
US-20120172340-A1 Compositions and Methods for Selectively Activating Human Sirtuins BIOMOL INTERNATIONAL L.P. (US) 2012-07-05 US claimed
WO-2006060654-A2 PESTICIDAL COMPOSITIONS AND METHODS DIVERGENCE, INC. (US) 2006-06-08 WO claimed
US-20060014705-A1 Compositions and methods for selectively activating human sirtuins BIOMOL INTERNATIONAL, INC. 2006-01-19 US claimed
WO-2006004722-A2 COMPOSITIONS AND METHODS FOR SELECTIVELY ACTIVATING HUMAN SIRTUINS BIOMOL RESEARCH LABORATORIES, INC. (US) 2006-01-12 WO claimed
US-20020198159-A1 USE OF STILBENE DERIVATIVES SUBSTITUTED IN POSITION 3 AS DEODORANT ACTIVE AGENTS IN COSMETIC COMPOSITIONS L'OREAL S.A. 2002-12-26 US claimed
EP-1029530-A1 Use of 3-substituted stilbene derivatives as deodorizing active principles in cosmetic compositions L'OREAL (FR) 2000-08-23 EP claimed
US-5314693-A Hydroxystilbene compounds KIORITZ CORPORATION (JP) 1994-05-24 US claimed
CN-1075845-A The pest control chemicals of antagonism pine wood nematodes KIORITZ CORP (JP) 1993-09-08 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172340-A1 Compositions and Methods for Selectively Activating Human Sirtuins SIRT1, SIRT7, SIRT5 LCK 4126/4885CCNB2 4268/4885CDK1 2159/4885
US-10729630-B2 Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH KRT18, CKAP4, JUP LCK 2868/4885CCNB2 1023/4885CDK1 871/4885
US-20020198159-A1 USE OF STILBENE DERIVATIVES SUBSTITUTED IN POSITION 3 AS DEODORANT ACTIVE AGENTS IN COSMETIC COMPOSITIONS DDT, HAAO, HDHD5 LCK 2166/4885CCNB2 3574/4885CDK1 4443/4885
US-20060014705-A1 Compositions and methods for selectively activating human sirtuins SIRT1, SIRT7, SIRT5 LCK 4126/4885CCNB2 4268/4885CDK1 2159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.